NEW YORK, November 21, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Kimberly Clark Corp (NYSE: KMB),
Colgate-Palmolive Company (NYSE: CL), Herbalife Ltd. (NYSE: HLF), Avon Products, Inc. (NYSE: AVP), and
Unilever plc (NYSE: UL). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Kimberly Clark Corp Research Report
On November 18, 2013, Kimberly Clark Corp (Kimberly Clark) announced the launch of the KimVent MICROCUFF Subglottic Suctioning Endotracheal Tube (ETT). Kimberly Clark stated that, the MICROCUFF subglottic ETT is the first subglottic suctioning ETT to receive FDA clearance for saline use, thus providing more effective clearing of potentially harmful clogs. According to the Company, MICROCUFF Subglottic ETT features an ergonomic subglottic suction valve and integrated rinse port, which allows controlled rinsing and suctioning of the lumen in a single cycle, without the need to open the suction circuit which results in more effective clearing. Megan Dutch Kelley, Pulmonary Services Education Coordinator at St. John Medical Center in Tulsa, Oklahoma said, "Clearing subglottic lines has been a persistent problem causing many of our respiratory therapists to disconnect the line to clear it, resulting in potential secretion exposure to both patient and the respiratory therapist. The KIMBERLY-CLARK MICROCUFF Subglottic ETT solves this problem with a more efficient system that enables us to keep a closed system to clear the line, protecting both patient and staff from contamination." The Full Research Report on Kimberly Clark Corp - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/a3ff_KMB
--
Colgate-Palmolive Company Research Report
On November 18, 2013, stocks of the Colgate-Palmolive Company (Colgate-Palmolive) dipped 0.91% to $65.18 at the close of trading session. Shares of Colgate-Palmolive rose by 0.14% over the past three trading sessions, while the S&P 500 rose by 0.53% during the same period. The Full Research Report on Colgate-Palmolive Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/4557_CL
--
Herbalife Ltd. Research Report
On November 6, 2013, Herbalife Ltd. (Herbalife) announced a partnership with the Brazilian government's "Science without Borders" program. According to the Company, the program will co-fund Ph.D. level student exchanges in the fields of biology, biomedical sciences and health, biotechnology, nutrition, food science and engineering. Herbalife stated that the said program is co-promoted by the Brazilian Ministry of Science, Innovation and Technology and the Ministry of Education through their supporting organizations including National Board for Scientific and Technological Development (CNPq), and the Coordination for Improvement of Higher Education Personnel (CAPES). The Company added that the agreement will co-fund one of the program's students in Brazil to conduct part of their Ph.D. work at the University of California Los Angeles (UCLA), where they will study under the guidance of faculty in the UCLA Center for Human Nutrition. The Full Research Report on Herbalife Ltd. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/9c80_HLF
--
Avon Products, Inc. Research Report
On November 18, 2013, stocks of Avon Products, Inc. (Avon) dipped 1.15% to end the trading day at $17.12. Shares of Avon lost 1.61% over the last three trading sessions while the Dow Jones Industrial Average rose 0.98% during the same period. The Full Research Report on Avon Products, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/676c_AVP
--
Unilever plc Research Report
On November 18, 2013, Unilever plc's (Unilever) stocks edged higher 0.45% to end the trading day at $40.16. Unilever's shares climbed 0.85% over the past three trading days, compared to the Dow Jones Industrial Average which rose 0.98% during the same period. The Full Research Report on Unilever plc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/9563_UL
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
AnalystsCorner.com
SOURCE Analysts' Corner
